Gene · 1237
NIH grants1,226
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,226
Download this page as JSON| Grant | Title | CCR8 papers | Newest fiscal year |
|---|---|---|---|
| R01AI137073 | DEFINING THE ROLE OF CELL MIGRATION IN HUMAN NK CELL DIFFERENTIATION | 1 | 2022 |
| R01AI147498 | Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids | 1 | 2022 |
| R01AR042527 | Oligoclonal T Cell Expansion and Rheumatoid Arthritis | 1 | 2022 |
| R01CA214911 | Ovarian Cancer Epigenetics, Immunity and Therapy | 1 | 2022 |
| R01CA218545 | Novel approach to attenuate small cell lung cancer growth and metastasis | 1 | 2022 |
| R01CA218802 | Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer | 1 | 2022 |
| R01CA227473 | (8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors | 1 | 2022 |
| R01CA229400 | Steroid hormone regulation of immune responses | 1 | 2022 |
| R01CA231112 | (PQ4) Novel tools for in vivo study of genetic interactions in cancer progression | 1 | 2022 |
| R01DE027980 | Human Herpesvirus Impact on Periodontal Inflammation | 1 | 2022 |
| R01HL056067 | T-Cell Targeting for GVHD | 1 | 2022 |
| R01HL084153 | Focal adhesion kinase regulation of lung vascular permeability and edemagenesis | 1 | 2022 |
| R01HL138414 | Role of Hedgehog Signaling in JAK2V617F Associated Myelofibrosis | 1 | 2022 |
| R01HL141237 | THE HUMAN INFANT AIRWAY EPITHELIUM AND RECURRENT WHEEZING AFTER RV AND RSV INFECTION | 1 | 2022 |
| R01HL141845 | Poly-omic Study of Asthma Exacerbations in Diverse Populations | 1 | 2022 |
| R01HL141852 | Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis | 1 | 2022 |
| R01HL147565 | IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation | 1 | 2022 |
| R21AR077266 | HERV-K immunity, a trigger of citrullination in rheumatoid arthritis? | 1 | 2022 |
| R21CA264381 | Computational approaches to unravel immune receptor sequencing for cancer immunotherapy | 1 | 2022 |
| R43DK133029 | Rapid, single-step precision engineering and pre-clinical evaluation of chimeric antigen receptor Regulatory T cells for Type 1 diabetes | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/grants?page=16